These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 11374178

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis.
    Ronday HK, Smits HH, Van Muijen GN, Pruszczynski MS, Dolhain RJ, Van Langelaan EJ, Breedveld FC, Verheijen JH.
    Br J Rheumatol; 1996 May; 35(5):416-23. PubMed ID: 8646430
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Urokinase-type plasminogen activator, receptor, and inhibitor correlating with gelatinase-B (MMP-9) contribute to inflammation in gouty arthritis of the knee.
    Chu SC, Yang SF, Lue KH, Hsieh YS, Hsiao TY, Lu KH.
    J Rheumatol; 2006 Feb; 33(2):311-7. PubMed ID: 16465663
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Interleukin 16 expression in relation to disease activity in rheumatoid arthritis.
    Blaschke S, Schulz H, Schwarz G, Blaschke V, Müller GA, Reuss-Borst M.
    J Rheumatol; 2001 Jan; 28(1):12-21. PubMed ID: 11196512
    [Abstract] [Full Text] [Related]

  • 9. Enhanced local production of osteopontin in rheumatoid joints.
    Ohshima S, Yamaguchi N, Nishioka K, Mima T, Ishii T, Umeshita-Sasai M, Kobayashi H, Shimizu M, Katada Y, Wakitani S, Murata N, Nomura S, Matsuno H, Katayama R, Kon S, Inobe M, Uede T, Kawase I, Saeki Y.
    J Rheumatol; 2002 Oct; 29(10):2061-7. PubMed ID: 12375312
    [Abstract] [Full Text] [Related]

  • 10. Soluble receptors for tumor necrosis factor and interleukin-2 in serum and synovial fluid of patients with rheumatoid arthritis, reactive arthritis and osteoarthritis.
    Steiner G, Studnicka-Benke A, Witzmann G, Höfler E, Smolen J.
    J Rheumatol; 1995 Mar; 22(3):406-12. PubMed ID: 7783054
    [Abstract] [Full Text] [Related]

  • 11. [Membrane and cytoplasmic expression of urokinase-type plasminogen activator receptor in synovial tissues of rheumatoid arthritis patients].
    Zhou JG, Guo XL, Yuan GH, Wei J, Tang Z, Yang MH.
    Zhonghua Nei Ke Za Zhi; 2007 Feb; 46(2):131-4. PubMed ID: 17445440
    [Abstract] [Full Text] [Related]

  • 12. High CCL18/PARC expression in articular cartilage and synovial tissue of patients with rheumatoid arthritis.
    Momohara S, Okamoto H, Iwamoto T, Mizumura T, Ikari K, Kawaguchi Y, Takeuchi M, Kamatani N, Tomatsu T.
    J Rheumatol; 2007 Feb; 34(2):266-71. PubMed ID: 17304652
    [Abstract] [Full Text] [Related]

  • 13. Effects of tiaprofenic acid on plasminogen activators and inhibitors in human OA and RA synovium.
    Pelletier JP, McCollum R, Cloutier JM, Martel-Pelletier J.
    Br J Rheumatol; 1992 Feb; 31 Suppl 1():19-26. PubMed ID: 1555050
    [Abstract] [Full Text] [Related]

  • 14. Peptide hormones and histamine in plasma and synovial fluid of patients with rheumatoid arthritis and osteoarthrosis.
    Rovensky J, Imrich R, Radikova Z, Simorova E, Greguska O, Vigas M, Macho L.
    Endocr Regul; 2005 Jan; 39(1):1-6. PubMed ID: 16107132
    [Abstract] [Full Text] [Related]

  • 15. Levels of hepatocyte growth factor in synovial fluid and serum of patients with rheumatoid arthritis and release of hepatocyte growth factor by rheumatoid synovial fluid cells.
    Yukioka K, Inaba M, Furumitsu Y, Yukioka M, Nishino T, Goto H, Nishizawa Y, Morii H.
    J Rheumatol; 1994 Dec; 21(12):2184-9. PubMed ID: 7699616
    [Abstract] [Full Text] [Related]

  • 16. Expression of matrix metalloproteinase 9 (96-kd gelatinase B) in human rheumatoid arthritis.
    Ahrens D, Koch AE, Pope RM, Stein-Picarella M, Niedbala MJ.
    Arthritis Rheum; 1996 Sep; 39(9):1576-87. PubMed ID: 8814070
    [Abstract] [Full Text] [Related]

  • 17. Synovial fluid and plasma selenium, copper, zinc, and iron concentrations in patients with rheumatoid arthritis and osteoarthritis.
    Yazar M, Sarban S, Kocyigit A, Isikan UE.
    Biol Trace Elem Res; 2005 Aug; 106(2):123-32. PubMed ID: 16116244
    [Abstract] [Full Text] [Related]

  • 18. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation.
    Brommer EJ, Dooijewaard G, Dijkmans BA, Breedveld FC.
    Thromb Haemost; 1992 Aug 03; 68(2):180-4. PubMed ID: 1412164
    [Abstract] [Full Text] [Related]

  • 19. Mobilization of fibrinolytic enzymes in synovial fluid and plasma of rheumatoid arthritis and spondyloarthropathy and their relation to radiological destruction.
    Wållberg-Jonsson S, Rantapää-Dahlqvist S, Nordmark L, Rånby M.
    J Rheumatol; 1996 Oct 03; 23(10):1704-9. PubMed ID: 8895144
    [Abstract] [Full Text] [Related]

  • 20. Functional autoantibodies against serpin E2 in rheumatoid arthritis.
    Maciejewska-Rodrigues H, Al-Shamisi M, Hemmatazad H, Ospelt C, Bouton MC, Jäger D, Cope AP, Charles P, Plant D, Distler JH, Gay RE, Michel BA, Knuth A, Neidhart M, Gay S, Jüngel A.
    Arthritis Rheum; 2010 Jan 03; 62(1):93-104. PubMed ID: 20039430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.